Citations 1
A phase II study of a combination of pemetrexed (Pem) and gemcitabine (Gem) in patients with metastatic breast cancer (MBC): An NCCTG study
X., C., Steen, Preston D. , Rowland, K. M., Niedringhaus, Robert D., Kugler, J. W., Perez, Edith A. , Adjei, Alex A. , Ma, C. X., Ingle, James N.
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 639-639
